Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Canopy Growth Corp T.WEED

Alternate Symbol(s):  T.WEED.DB | CGC

Healthcare Cannabis
Canopy Growth Corporation is a cannabis company. It delivers innovative products with a focus on premium and mainstream cannabis brands, including Doja, 7ACRES, Tweed, and Deep Space, in addition to category-defining vaporizer technology made in Germany by Storz & Bickel. The principal activities of the Company are the production, distribution and sale of a diverse range of cannabis and cannabinoid-based products for both adult-use and medical purposes under a portfolio of distinct brands in Canada. Its Canada cannabis segment includes the production, distribution, and sale of a range of cannabis, hemp, and cannabis related products in Canada. International markets cannabis segment includes the production, distribution, and sale of a range of cannabis and hemp products internationally. Storz & Bickel segment includes the production, distribution, and sale of vaporizers. This Works segment includes the production, distribution and sale of beauty, skincare, wellness and sleep products.


TSX:WEED - Post by User

Canopy Growth Corp > “Full legalization” is not required
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(500)
•••
Comment by Homestretch4meon Feb 26, 2021 10:31am
133 Views
Post# 32670348

RE:RE:“Full legalization” is not required

RE:RE:“Full legalization” is not required No offense , I don't know you but I'm getting tired of all the uneducated investors coming on here and just spewing garbage. Why are you on this board if you know nothing about this company or their arrangement with acreage.

If a triggering event happens, canopy growth does not have the option to take over acreage, they must take over acreage. There is no option when a triggering event happens. Go read the deal and until you have please STFU.

Sampic wrote: I agree but one thing has me confused why did Acerage file an S1 with sec if Canopy going to get in USA would they not merge making an Acerage uplist unnecessary?Or maybe they are not going to pull trigger on Acrg and merge or buyout a different mso?


<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities